Product details:

ISBN13:9780323956505
ISBN10:0323956505
Binding:Hardback
No. of pages:630 pages
Size:276x215 mm
Weight:1960 g
Language:English
688
Category:

Linking Neuroscience and Behavior in COVID-19

 
Publisher: Academic Press
Date of Publication:
 
Normal price:

Publisher's listprice:
EUR 220.00
Estimated price in HUF:
90 783 HUF (86 460 HUF + 5% VAT)
Why estimated?
 
Your price:

81 705 (77 814 HUF + 5% VAT )
discount is: 10% (approx 9 078 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
  Piece(s)

 
Long description:
Linking Neuroscience and Behavior in COVID-19 examines the effect of both the virus and the pandemic on behavior and mental health. Chapters look at the burden of the COVID-19 pandemic on those with pre-existing conditions, including Parkinson's disease and multiple sclerosis. The ongoing consequences of the pandemic on the mental health of the broad populace are discussed. As well as the neurological effects of the virus itself, chapters discuss psychological concerns including depression and anxiety. Finally, the chapters also include aspects relevant to managing care and the treatment of conditions. A broad range of conditions preceding, caused by, or emerging for the first time during the pandemic are also detailed.
Table of Contents:
Preface

Section A: Introductory chapters and setting the scene

1. The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic

2. Different variants of SARS-CoV-2

3. Lateral flow assay for SARS-CoV-2 infection: Uses and limitations

4. Linking community participation, mobility disabilities, and the COVID-19 pandemic

5. Influence of the sources used to obtain information on COVID-19 and their impact on mental health

Section B: Impact on behavior and psychology

6. The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors

7. Impact of COVID-19 on behavior in autism spectrum disorder

8. Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond

9. Compulsive hoarding in the COVID-19 pandemic

10. The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic

11. The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceived
stress

12. The Covid-19 pandemic and the occupational overload of health professionals: Indicators of
burnout

13. Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications

14. Acute neurocognitive disorder as a presenting manifestation of COVID-19

15. Mental health and the impact of confinement

16. Cannabis use in the COVID-19 pandemic: Changes in different populations and implications
for policy

17. Impact of COVID-19 on mental health in women: Socioeconomic groups and global aspects

18. Quality of life assessment of patients after COVID-19

19. COVID-19 pandemic and remote working: Toward a new way of working

20. Long COVID and its persistence: A focus on mental health

21. The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of life

Section C: Effects on neurological structures and mechanisms

23. Linking pediatric COVID-19 with basal ganglia and dentate nucleus

24. Sensory disorders, neuroinflammation, and COVID-19

25. The effects of COVID-19 isolations on nonmotor features of Parkinson's disease

26. Myelitis following COVID-19: The road so far

27. The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine

28. Assessing the impact of prenatal SARS-CoV-2 exposure on infants' neurodevelopment: A comprehensive analysis of current evidence

29. Electroencephalographic features with COVID-19

30. Survivors of COVID-19 and clinical neuropsychological domain characteristics

31. Neuroinflammation following SARS-CoV-2 infection

32. Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-19

33. Impact of COVID-19 on the brain: Antibodies against brain stem antigens

34. The kynurenine pathway and role in mental health of post-COVID-19 patients

Section D: Management, support and treatments

35. Management of brain tumors in the COVID-19 pandemic

36. The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase

37. Long COVID and the potential use of palmitoylethanolamide

38. Cognitive assessments in post-COVID syndrome: A focus on the neuropsychological tests and
protocols

39. Supporting individuals with intellectual and developmental disabilities during the COVID-19
pandemic

40. Preserving well-being and quality of life through school-based interventions focused on physical
activity during the COVID-19 pandemic

41. Hesitancy in using COVID 19 prevention behaviors among African Americans: Strategies to
build confidence

42. New strategies for psychological well-being at work

43. Mitigating mental health changes with virtual reality technology during Covid-19: A narrative

44. Music therapy for patients with neurological disorders during COVID-19 pandemic

45. Mental health and the modulating effects of receiving the COVID-19 vaccination

46. Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic

47. Social anxiety disorder and Covid 19: Treatment with cognitive behavioral therapy

48. Burnout during the COVID-19 pandemic: Modulating role of mindfulness

Section E: Case studies with mini review

49. Case study: Evaluation of a long Covid assessment service (LCAS)

50. Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic

51. Case study: Restless leg syndrome associated with COVID-19

Section F: Resources

52. Recommended resources for linking neuroscience and behavior in coronavirus disease
(COVID-19)